Real-Life Experience Regarding Clinical Characteristics and Treatment Outcome in Non-Cutaneous Peripheral T-Cell Lymphomas: A Multicenter Study of the Turkish Hematology Research and Education Group (ThREG)
TURKISH JOURNAL OF HEMATOLOGY, vol.39, no.3, pp.170-177, 2022 (SCI-Expanded, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 39 Issue: 3
- Publication Date: 2022
- Doi Number: 10.4274/tjh.galenos.2022.2022.0052
- Journal Name: TURKISH JOURNAL OF HEMATOLOGY
- Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CINAHL, EMBASE, MEDLINE, TR DİZİN (ULAKBİM)
- Page Numbers: pp.170-177
- Keywords: Lymphomas, Autologous stem cell transplantation, T-cell lymphomas, Non-Hodgkin lymphoma, HIGH-DOSE CHEMOTHERAPY, AMERICAN SOCIETY, UP-FRONT, TRANSPLANTATION, SURVIVAL, GUIDELINES, PROGNOSIS, DISEASE, COHORT
- Open Archive Collection: AVESIS Open Access Collection
- Ondokuz Mayıs University Affiliated: Yes
Abstract
Objective: Peripheral T-cell lymphomas (PTCLs) are an uncommon and quite heterogeneous group of disorders, representing only 10%-15% of all non-Hodgkin lymphomas. Although both molecular and clinical studies have increased in recent years, we still have little knowledge regarding real-life practice with PTCLs. In this study, we aimed to investigate the clinical characteristics and treatment outcomes of a large population-based cohort of patients presenting with systemic non-cutaneous PTCL.